Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Date Journal Bone Marrow Disease
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes Nov 2016 N Engl J Med myelodysplastic syndromes (MDS)
Therapy-related myelodysplastic syndromes, or are they? Nov 2016 Blood Rev myelodysplastic syndromes (MDS)
WT1 Expression in Patients with Myelodysplastic Syndromes: A Variety of Possibilities in Future Clinical Practice Nov 2016 Acta Haematol myelodysplastic syndromes (MDS)
Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study Nov 2016 Prostate myelodysplastic syndromes (MDS)
Eculizumab treatment improved renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria Nov 2016 Int J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Implications of molecular genetic diversity in myelodysplastic syndromes Nov 2016 Curr Opin Hematol myelodysplastic syndromes (MDS)
Polymorphisms of Interlukin-1β rs16944 confer susceptibility to myelodysplastic syndromes Nov 2016 Life Sci. myelodysplastic syndromes (MDS)
Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS) Nov 2016 Leuk Res myelodysplastic syndromes (MDS)
Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II Nov 2016 Ann Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis Nov 2016 PLoS One myelodysplastic syndromes (MDS)